PROVECTUS BIOPHARMACEUTICALS, INC. Public Float
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Public Float of $30.59 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $30.59M.
- 2024-06-30: Entity Public Float $51.63M.
- 2023-06-30: Entity Public Float $45.53M.
- 2022-06-30: Entity Public Float $22.59M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $30.59M 10-K · filed 2026-03-26 |
| 2024-06-30 | $51.63M 10-K/A · filed 2025-05-16 |
| 2023-06-30 | $45.53M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $22.59M 10-K · filed 2023-03-30 |
| 2021-06-30 | $26.78M 10-K · filed 2022-03-29 |
| 2020-06-30 | $16.53M 10-K · filed 2021-03-02 |
| 2019-06-28 | $23.30M 10-K · filed 2020-03-05 |
| 2018-06-29 | $26.05M 10-K · filed 2019-03-07 |
| 2017-06-30 | $11.01M 10-K · filed 2018-03-23 |
| 2016-06-30 | $75.81M 10-K · filed 2017-03-31 |
| 2015-06-30 | $105.47M 10-K · filed 2016-03-30 |
| 2014-06-30 | $142.20M 10-K · filed 2015-03-12 |
| 2013-06-28 | $77.15M 10-K · filed 2014-03-13 |
| 2012-06-29 | $75.47M 10-K · filed 2013-03-14 |
| 2011-06-30 | $84.89M 10-K · filed 2012-03-14 |
| 2010-06-30 | $79.39M 10-Q · filed 2011-11-08 |